The European Commission has confirmed a CHMP recommendation that Nycomed's pantoprazole 20mg tablets be available without prescription throughout the EU for the short-term treatment of gastroesophageal reflux symptoms in adults.
It is the second product approved in the EU for OTC status through the centralised procedure, after GlaxoSmithKline's alli (orlistat...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?